Key result
Capecitabine chemotherapy is linked to hypertriglyceridemia as an underdiagnosed adverse effect.
Why the study?
Hypertriglyceridemia as a side effect of capecitabine chemotherapy is underrecognized and may be underdiagnosed.
Highlights hypertriglyceridemia as a potential, underdiagnosed side effect of capecitabine chemotherapy.
May warrant lipid monitoring on capecitabine; leaves open causality and need for prospective trials.
To the EditorA 57-year-old patient was diagnosed with a stage II adenocarcinoma of the caecum.He elected to have adjuvant chemotherapy with capecitabine, 2 500mg/m2 divided in two daily doses for 1...
No takes yet. Share an insight, caveat, or question.
Orphanos et al. (2010) studied this question. Capecitabine chemotherapy is associated with hypertriglyceridemia, representing an underdiagnosed adverse effect of this treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: